Joel Scanlon

Joel Scanlon

Digital Specialist and Founder of News-Medical.Net

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Articles from Joel

Olympus Pacific Minerals Reports Drilling on Jugan Gold Deposit Continues to Yield Positive Results

Atacama Pacific Gold Announces Additional Assay Results from Phase III Drill Program

Namibia Rare Earths Reports Drill Results from Lofdal Project

Kryso Resources Announces Positive Drilling Results from Pakrut Area

Interoil Offers Updates for Triceratops-2 Well

MENA Declares Oil Production at Lagia Oil Field

New Millennium Iron Announces Drilling Results from Lac Ritchie Property

Mag Copper Reports Mineral Resource Estimate Results from Magusi River Deposit

Freegold Ventures Reports Ongoing Drilling Results from Golden Summit Project

Rio Tinto Becomes Member of CBMX’s Iron Ore Trading Channel

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.